Cargando…

Short-term Follow-up Results of Drug-eluting Stenting in Premature Coronary Artery Disease Patients with Multiple Atherosclerotic Risk Factors

BACKGROUND: Premature coronary artery disease (CAD) is a special entity with a strong link to familial hypercholesterolemia, family history of premature CAD, or multiple coexistent atherosclerotic risk factors. Drug-eluting stenting (DES), including paclitaxel-eluting stenting (PES) and sirolimus-el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ming-Hsiung, Lee, Wen-Lieng, Wang, Kuo-Yang, Hsieh, Yu-Cheng, Liu, Tsun-Jui, Lin, I-Hsiang, Lin, Wei-Wen, Ting, Chih-Tai, Liang, Kae-Woei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier. Published by Elsevier B.V. 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129192/ https://www.ncbi.nlm.nih.gov/pubmed/18653396 http://dx.doi.org/10.1016/S1726-4901(08)70136-9

Ejemplares similares

Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents
por: Su, Chieh-Shou, et al.
Publicado: (2019)

Clinical outcomes of coronary artery bifurcation disease patients underwent Culotte two-stent technique: a single center experience
por: Chang, Chih-Feng, et al.
Publicado: (2019)

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock
por: Mao, Chun-Tai, et al.
Publicado: (2019)

Incidence and Mechanisms of Coronary Perforations during Rotational Atherectomy in Modern Practice
por: Wang, Yen-Hsiang, et al.
Publicado: (2020)

Rotablation in the treatment of high-risk patients with heavily calcified left-main coronary lesions
por: Chiang, Meng-Hsiu, et al.
Publicado: (2013)

Rotablation in Patients with Advanced Renal Insufficiency through End-Stage Renal Disease: Short- and Intermediate-Term Results
por: Lo, Wei-Jung, et al.
Publicado: (2022)

Coronary Stent Infection Presented as Recurrent Stent Thrombosis
por: Lai, Chih-Hung, et al.
Publicado: (2017)

Acute Angiographic and Intermediate-Term Clinical Results of Patients with Non-Left Main Coronary Bifurcation Lesions Treated with BVS by Jailed Semi-Inflated Balloon Technique and Provisional Side-Branch Stenting Strategy
por: Su, Chieh-Shou, et al.
Publicado: (2019)

The Procedural and Clinical Outcomes of Rotational Atherectomy in Patients Presenting With Acute Myocardial Infarction
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee, Cheng-Hung, et al.
Publicado: (2018)

Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Lee, Cheng-Hung, et al.
Publicado: (2017)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Transcarotid Transcatheter Aortic Valve Replacement in an Octogenarian With Complex Type B Aortic Dissection and Aneurysm: A Case Report
por: Liang, Kae-Woei, et al.
Publicado: (2021)

Case Report: Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With Worsening Heart Failure—A Successful Resolution Using Non-vitamin K Antagonist Oral Anti-coagulant
por: Liang, Kae-Woei, et al.
Publicado: (2021)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

Rotational atherectomy for chronically and totally occluded coronary lesions: A propensity score-matched outcomes study
por: Tsai, Tien-Chien, et al.
Publicado: (2022)

Novel usage of everolimus-eluting coronary stent for intracranial atherosclerotic disease: a technical report and case series
por: Coulibaly, Nangorgo Jean Oumar, et al.
Publicado: (2023)

STEMI patients receiving percutaneous coronary intervention for a culprit lesion with coronary artery bifurcation—efficacy and safety of the jailed semi-inflated balloon
por: Lin, Tzu-Hsiang, et al.
Publicado: (2023)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents
por: Polavarapu, Raghava Sarma, et al.
Publicado: (2023)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus
por: Liang, Kae-Woei, et al.
Publicado: (2017)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
por: Hassan, Ameer E., et al.
Publicado: (2020)

Long-term outcomes of drug-eluting stent implantation in patients with symptomatic extra- and intracranial atherosclerotic stenoses
por: Kim, Junhyung, et al.
Publicado: (2020)

Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Application of rotational atherectomy in the drug-eluting stent era
por: Chen, Chun-Chi, et al.
Publicado: (2013)

Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture
por: Ho, Dong-Ru, et al.
Publicado: (2021)

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
por: Lee, Chen-Hung, et al.
Publicado: (2019)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents: An updated meta-analysis
por: Chen, Yun-lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1i6cq1769jg6rd0c53oo3f3pl9